October 4, 2013

John Carris Investments Charged by FINRA with Defrauding Investors Who Purchased Fibrocell Science Inc (FCSC)

business man holding his head with text asking questions about stock broker misconduct

The Financial Industry Regulatory Authority, FINRA, has charged John Carris Investments LLC of New York with defrauding and misleading its investors. Invictus Capital Inc, which owns Carris, sold stock in Fibrocell Science Inc (FCSC) while at the same time selling its own shares in the biotechnology company, FINRA said recently. FINRA alleges Carris mislead investors about the financial health of Invictus according to a recent article in the Wall Street Journal.

Carris' Chief Executive, George Carris allegedly failed to disclose the firm's payments covering his personal expenses. FINRA claims that over $300K listed as office expenses included George Carris' personal expenses, and the firm allegedly failed to pay hundreds of thousands of dollars in employee payroll taxes.

Carris has underwritten several Fibrocell securities offerings between 2009 and 2012. The most recent was a common stock offering in October 2012 as a co-placement agent with Barclays PLC (BCS) and MTS Securities LLC as lead agents. According to WSJ, Finra alleges the firm--and its head trader Jason Barter--manipulated the stock while acting as placement agent between May and September 2010.

Carris misled investors, between October 2010 and 2012, as it allegedly solicited new investments to pay dividends to early investors without disclosing the failing financial condition of Invictus. By March 2013, Invictus Capital defaulted on $2 million of Invictus notes sold to earlier John Carris Investments customers, Finra said.

Penalties may include a fine, an order to pay restitution, censure, suspension, or even bar from the securities industry.

If you were sold Fibrocell Science Inc (FCSC), by John Carris Investments LLC or Invictus Capital Inc, or Barclays PLC (BCS) or MTS Securities LLC, call for a free consultation on how to potentially recover your losses. To speak with an attorney at Soreide Law Group call 888-760-6552.

S H A R E   T H I S   P O S T

Recent Posts

September 14, 2026
Westpark Capital Sanctioned By FINRA For Failure To Supervise GWG L Bond Sales

Investors might have sustained financial harm through WestPark Capital Inc. [CRD: 39914, Los Angeles, California], according to publicly available information found on Financial Industry Regulatory Authority BrokerCheck. WestPark Capital has been registered with FINRA since 1996 and maintains its headquarters in Los Angeles, California. Keep reading to discover more about the regulatory action involving the […]

September 13, 2026
James Tighe Of Morgan Stanley Barred By FINRA After Investigation

Investors might have sustained losses due to securities broker James Fredrick Tighe [CRD: 3129233, Phoenix, Arizona], and Financial Industry Regulatory Authority barred him, based on public information on BrokerCheck. Tighe was associated with Morgan Stanley from June 1, 2009, through January 14, 2025. Continue reading to find out more about Tighe’s regulatory and client dispute […]

September 13, 2026
Sung Cho Of Citigroup Global Markets Barred By FINRA Following Investigation

Investors potentially experienced sales practice violations by securities broker Sung Moo Cho (also known as Sam Cho) [CRD: 5015906, New York, New York], and FINRA barred him, given the public information found on FINRA BrokerCheck. Cho was associated with Ameriprise Financial Services from January 22, 2021, to October 21, 2025, and Citigroup Global Markets from […]

Contact us Nationwide USA
2401 E. Atlantic Blvd., Suite 305, Pompano Beach, FL 33062
Helping clients recover money across the USA
search
Copyright © 2025 Soreide Law Group, PLLC  |  All Rights Reserved